Pradžia › Širdies priepuolis › Konektikutas
Širdies priepuolis klinikiniai tyrimai Konektikutas
7 tyrimai dėl Širdies priepuolis ieško dalyvių vietose Konektikutas.
Miestai Konektikutas
Oficialus tyrimo tekstas (anglų kalba)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Greater Hartford Nephrology, LLC, Bloomfield
- Nephrology and Hypertension Associates PC, Middlebury
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Bridgeport Hospital, Bridgeport
- Hartford Hospital, Hartford
- Chase Medical Research LLC, Waterbury
Renkami dalyviai3 fazė
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-09-04 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Gandelman Cardiology, PC, Greenwich
- ClinTrial Hamden, Hamden
- Chase Medical Research LLC, Waterbury
Renkami dalyviai3 fazė
Amžius nuo 50 iki 105 · Visoms lytims · Atnaujinta 2026-08-21 · NCT07136012Circulating Markers for Ischemic Heart Disease
- University of Connecticut Health Center, Farmington
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-17 · NCT00762333Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
- University of Connecticut Health Center, Farmington
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-17 · NCT04321512Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Yale School of Medicine, New Haven
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-24 · NCT04774159Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
- ROMTech, Brookfield
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-07-24 · NCT05972070Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.